• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

2016 年世卫组织淋巴瘤分类更新的临床影响。

Clinical Impact of the 2016 Update to the WHO Lymphoma Classification.

机构信息

Division of Oncology, Department of Medicine, Stanford University School of Medicine, Stanford, CA, USA.

Department of Pathology, Stanford University School of Medicine, Stanford, CA, USA.

出版信息

Curr Treat Options Oncol. 2017 Jul;18(7):45. doi: 10.1007/s11864-017-0483-z.

DOI:10.1007/s11864-017-0483-z
PMID:28670664
Abstract

The 2016 revision of the WHO classification of lymphoid neoplasms includes new entities along with a clearer definition of provisional and definitive subtypes based on better understanding of the molecular drivers of lymphomas. These changes impact current treatment paradigms and provide a framework for future clinical trials. Additionally, this update recognizes several premalignant or predominantly indolent entities and underscores the importance of avoiding unnecessarily aggressive treatment in the latter subsets.

摘要

2016 年版世界卫生组织淋巴造血组织肿瘤分类包括了新的病种,同时根据对淋巴瘤分子驱动因素的更好理解,对暂定和明确的亚型进行了更清晰的定义。这些变化影响了当前的治疗模式,并为未来的临床试验提供了框架。此外,本次更新还认识到了一些潜在恶性或主要惰性的实体肿瘤,并强调了在后一组避免不必要的激进治疗的重要性。

相似文献

1
Clinical Impact of the 2016 Update to the WHO Lymphoma Classification.2016 年世卫组织淋巴瘤分类更新的临床影响。
Curr Treat Options Oncol. 2017 Jul;18(7):45. doi: 10.1007/s11864-017-0483-z.
2
New developments in non-Hodgkin lymphoid malignancies.非霍奇金淋巴瘤的新进展。
Pathology. 2021 Apr;53(3):349-366. doi: 10.1016/j.pathol.2021.01.002. Epub 2021 Mar 5.
3
Aggressive B cell lymphomas in the 2017 revised WHO classification of tumors of hematopoietic and lymphoid tissues.2017年版《世界卫生组织造血与淋巴组织肿瘤分类》中的侵袭性B细胞淋巴瘤。
Ann Diagn Pathol. 2019 Feb;38:6-10. doi: 10.1016/j.anndiagpath.2018.09.014. Epub 2018 Oct 2.
4
Aggressive B-cell lymphomas in the update of the 4th edition of the World Health Organization classification of haematopoietic and lymphatic tissues: refinements of the classification, new entities and genetic findings.《世界卫生组织造血与淋巴组织分类第4版更新中的侵袭性B细胞淋巴瘤:分类细化、新实体及遗传学发现》
Br J Haematol. 2017 Sep;178(6):871-887. doi: 10.1111/bjh.14744. Epub 2017 Jul 27.
5
Lymphoma classification update: T-cell lymphomas, Hodgkin lymphomas, and histiocytic/dendritic cell neoplasms.淋巴瘤分类更新:T 细胞淋巴瘤、霍奇金淋巴瘤和组织细胞/树突状细胞肿瘤。
Expert Rev Hematol. 2017 Mar;10(3):239-249. doi: 10.1080/17474086.2017.1281122. Epub 2017 Jan 29.
6
The World Health Organization classification of malignant lymphoma: incidence and clinical prognosis in HTLV-1-endemic area of Fukuoka.世界卫生组织恶性淋巴瘤分类:福冈HTLV-1流行地区的发病率及临床预后
Pathol Int. 2002 Jan;52(1):1-12. doi: 10.1046/j.1440-1827.2002.01308.x.
7
[Overview of lymphoid neoplasms in the fourth edition of the WHO classification].[《世界卫生组织分类第四版中的淋巴样肿瘤概述》]
Rinsho Byori. 2012 Jun;60(6):560-4.
8
Lymphoma classification update: B-cell non-Hodgkin lymphomas.淋巴瘤分类更新:B细胞非霍奇金淋巴瘤
Expert Rev Hematol. 2017 May;10(5):405-415. doi: 10.1080/17474086.2017.1318053. Epub 2017 Apr 24.
9
[2016 revision of the WHO classification of lymphoid neoplasms].[世界卫生组织淋巴样肿瘤分类(2016年修订版)]
Rinsho Ketsueki. 2017;58(10):2188-2193. doi: 10.11406/rinketsu.58.2188.
10
[R.E.A.L. classification of non-Hodgkin lymphoma from the clinico-oncologic viewpoint].[从临床肿瘤学视角看非霍奇金淋巴瘤的R.E.A.L.分类]
Praxis (Bern 1994). 1998 Jun 3;87(23):793-800.

引用本文的文献

1
IgA nephropathy.IgA 肾病。
Nat Rev Dis Primers. 2023 Nov 30;9(1):67. doi: 10.1038/s41572-023-00476-9.
2
Real-world treatment patterns, discontinuation and clinical outcomes in patients with B-cell lymphoproliferative diseases treated with BTK inhibitors in China.中国接受 BTK 抑制剂治疗的 B 细胞淋巴增生性疾病患者的真实世界治疗模式、停药和临床结局。
Front Immunol. 2023 Jul 7;14:1184395. doi: 10.3389/fimmu.2023.1184395. eCollection 2023.
3
Coexistence of diffuse large B-cell lymphoma, acute myeloid leukemia, and untreated lymphoplasmacytic lymphoma/waldenström macroglobulinemia in a same patient: A case report.

本文引用的文献

1
Approach to the diagnosis and treatment of high-grade B-cell lymphomas with MYC and BCL2 and/or BCL6 rearrangements.伴有 MYC 和 BCL2 及/或 BCL6 重排的高级别 B 细胞淋巴瘤的诊断与治疗方法。
Blood. 2017 Jan 19;129(3):280-288. doi: 10.1182/blood-2016-02-636316. Epub 2016 Nov 7.
2
Lymphoplasmacytic Lymphoma With a Non-IgM Paraprotein Shows Clinical and Pathologic Heterogeneity and May Harbor MYD88 L265P Mutations.伴有非IgM副蛋白的淋巴浆细胞淋巴瘤表现出临床和病理异质性,且可能存在MYD88 L265P突变。
Am J Clin Pathol. 2016 Jun;145(6):843-51. doi: 10.1093/ajcp/aqw072. Epub 2016 Jun 21.
3
Venetoclax in relapsed or refractory chronic lymphocytic leukaemia with 17p deletion: a multicentre, open-label, phase 2 study.
同一患者同时存在弥漫性大B细胞淋巴瘤、急性髓系白血病和未经治疗的淋巴浆细胞性淋巴瘤/华氏巨球蛋白血症:一例报告。
World J Clin Cases. 2023 Jun 26;11(18):4295-4305. doi: 10.12998/wjcc.v11.i18.4295.
4
Plasma cells arise from differentiation of clonal lymphocytes and secrete IgM in Waldenström macroglobulinemia.浆细胞由克隆性淋巴细胞分化产生,并在华氏巨球蛋白血症中分泌IgM。
iScience. 2022 Aug 4;25(8):104856. doi: 10.1016/j.isci.2022.104856. eCollection 2022 Aug 19.
5
Landscape of immunoglobulin heavy chain gene repertoire and its clinical relevance to LPL/WM.免疫球蛋白重链基因库的特征及其与 LPL/WM 的临床相关性。
Blood Adv. 2022 Jul 12;6(13):4049-4059. doi: 10.1182/bloodadvances.2022007279.
6
Advances in Multi-Omics Study of Prognostic Biomarkers of Diffuse Large B-Cell Lymphoma.多组学研究弥漫性大 B 细胞淋巴瘤预后生物标志物的进展。
Int J Biol Sci. 2022 Jan 9;18(4):1313-1327. doi: 10.7150/ijbs.67892. eCollection 2022.
7
18F-FDG PET/CT imaging in the diagnosis of drug-induced lung disease and pulmonary infection in lymphoma.18F-FDG PET/CT 成像在淋巴瘤相关药物性肺疾病和肺部感染诊断中的应用。
Medicine (Baltimore). 2021 Sep 17;100(37):e27107. doi: 10.1097/MD.0000000000027107.
8
Waldenström's Macroglobulinemia: An Exploration into the Pathology and Diagnosis of a Complex B-Cell Malignancy.华氏巨球蛋白血症:对一种复杂B细胞恶性肿瘤的病理学与诊断的探索
J Blood Med. 2021 Aug 30;12:795-807. doi: 10.2147/JBM.S267938. eCollection 2021.
9
Ultrasound-Guided Anterior Mediastinotomy: A Feasible Tool for Critical Lymphoma Patients.超声引导下前纵隔切开术:一种适用于重症淋巴瘤患者的可行工具。
Healthcare (Basel). 2021 Jun 21;9(6):770. doi: 10.3390/healthcare9060770.
10
Age is the most important predictor of survival in diffuse large B-cell lymphoma patients achieving event-free survival at 24 months: a Swedish population-based study.年龄是弥漫性大B细胞淋巴瘤患者实现24个月无事件生存的最重要生存预测因素:一项基于瑞典人群的研究。
Br J Haematol. 2021 Jun;193(5):906-914. doi: 10.1111/bjh.17206. Epub 2021 May 5.
Venetoclax 治疗伴有 17p 缺失的复发或难治性慢性淋巴细胞白血病:一项多中心、开放标签、2 期研究。
Lancet Oncol. 2016 Jun;17(6):768-778. doi: 10.1016/S1470-2045(16)30019-5. Epub 2016 May 10.
4
Comprehensive genomic profiling of orbital and ocular adnexal lymphomas identifies frequent alterations in MYD88 and chromatin modifiers: new routes to targeted therapies.眼眶和眼附属器淋巴瘤的综合基因组分析确定了MYD88和染色质修饰因子的频繁改变:靶向治疗的新途径。
Mod Pathol. 2016 Jul;29(7):685-97. doi: 10.1038/modpathol.2016.79. Epub 2016 Apr 22.
5
Randomized Phase 2 Open-Label Study of R-CHOP ± Bortezomib in Patients (Pts) With Untreated Non-Germinal Center B-Cell-like (Non-GCB) Subtype Diffuse Large Cell Lymphoma (DLBCL): Results From the Pyramid Trial (NCT00931918).R-CHOP方案±硼替佐米用于未经治疗的非生发中心B细胞样(Non-GCB)亚型弥漫性大B细胞淋巴瘤(DLBCL)患者的随机2期开放标签研究:金字塔试验(NCT00931918)结果
Clin Adv Hematol Oncol. 2016 Feb;14(2 Suppl 1):15-6.
6
The 2016 revision of the World Health Organization classification of lymphoid neoplasms.《世界卫生组织淋巴组织肿瘤分类(2016年修订版)》
Blood. 2016 May 19;127(20):2375-90. doi: 10.1182/blood-2016-01-643569. Epub 2016 Mar 15.
7
Impact of dual expression of MYC and BCL2 by immunohistochemistry on the risk of CNS relapse in DLBCL.免疫组织化学双重表达 MYC 和 BCL2 对弥漫性大 B 细胞淋巴瘤中枢神经系统复发风险的影响。
Blood. 2016 May 5;127(18):2182-8. doi: 10.1182/blood-2015-10-676700. Epub 2016 Feb 1.
8
Complete Surgical Excision Is Essential for the Management of Patients With Breast Implant-Associated Anaplastic Large-Cell Lymphoma.完整手术切除对于乳房植入物相关间变性大细胞淋巴瘤患者的治疗至关重要。
J Clin Oncol. 2016 Jan 10;34(2):160-8. doi: 10.1200/JCO.2015.63.3412. Epub 2015 Nov 30.
9
MYC in DLBCL: partners matter.MYC 在弥漫性大 B 细胞淋巴瘤中的作用:伙伴很重要。
Blood. 2015 Nov 26;126(22):2439-40. doi: 10.1182/blood-2015-10-671362.
10
Breast implant-associated anaplastic large cell lymphoma: two distinct clinicopathological variants with different outcomes.乳房植入物相关间变性大细胞淋巴瘤:两种具有不同预后的独特临床病理变体。
Ann Oncol. 2016 Feb;27(2):306-14. doi: 10.1093/annonc/mdv575. Epub 2015 Nov 23.